Sigma slashes earnings outlook, warns on sales
The pharmaceutical wholesaler says it now expects full-year 2022 earnings to be down 10 per cent, rather than the 5 per cent growth it had flagged.
Source: afr.com
Stay updated with breaking news from Jeff Sells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The pharmaceutical wholesaler says it now expects full-year 2022 earnings to be down 10 per cent, rather than the 5 per cent growth it had flagged.